Authors/Disclosures
|
|
No disclosure on file |
|
Cynthia L. Harden, MD
(Xenon Pharmaceuticals Inc)
|
Dr. Harden has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc.. Dr. Harden has stock in Xenon Pharmaceuticals Inc.. Dr. Harden has received intellectual property interests from a discovery or technology relating to health care. |
|
Mar Carreno, MD
(Cleveland Clinic Foundation)
|
No disclosure on file |
|
Helena Gama
|
Helena Gama has received personal compensation for serving as an employee of Bial-Portela & Cª S.A.. |
|
Patricio Soares-da-Silva
|
Patricio Soares-da-Silva has received personal compensation for serving as an employee of Bial - Portela & Cª S.A.. Patricio Soares-da-Silva has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Bial - Portela & Cª S.A.. |
|
Gustavo Saposnik, MD
(Director, Clinical Outcomes & Decision Neuroscience Research Centre)
|
Dr. Saposnik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Saposnik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIHSS. The institution of Dr. Saposnik has received research support from Roche. The institution of Dr. Saposnik has received research support from Heart and Stroke Foundation of Canada. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Todd Grinnell, PhD
|
Todd Grinnell, PhD has received personal compensation for serving as an employee of Sunovion Pharmaceuticals Inc.. |
|
David E. Blum, MD
|
Dr. Blum has received personal compensation for serving as an employee of Neurona Therapeutics. Dr. Blum has stock in Neurona Therapeutics. |